CAPLIN POINT LABORATORIES LTD.

Company Profile

CAPLIN POINT LABORATORIES LTD. had its IPO on under the ticker symbol CAPPL.

The company operates in the sector and industry. CAPLIN POINT LABORATORIES LTD. has a staff strength of 0 employees.

Stock update

Shares of CAPLIN POINT LABORATORIES LTD. opened at ₹1040 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹961.8 - ₹1048, and closed at ₹972.85.

This is a -6.24% slip from the previous day's closing price.

A total volume of 58,816 shares were traded at the close of the day’s session.

In the last one week, shares of CAPLIN POINT LABORATORIES LTD. have slipped by -9.1%.

CAPLIN POINT LABORATORIES LTD.'s Key Ratios

CAPLIN POINT LABORATORIES LTD. has a market cap of ₹79.85 billion, indicating a price to book ratio of 3.3182 and a price to sales ratio of 4.1348.

In the last 12-months CAPLIN POINT LABORATORIES LTD.’s revenue was ₹0 with a gross profit of ₹4.43 billion and an EBITDA of ₹0. The EBITDA ratio measures CAPLIN POINT LABORATORIES LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, CAPLIN POINT LABORATORIES LTD.’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q2, CAPLIN POINT LABORATORIES LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

CAPLIN POINT LABORATORIES LTD.’s PE and PEG Ratio

Forward PE

0

Trailing PE

36.7195

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into CAPLIN POINT LABORATORIES LTD.’s profitability.

CAPLIN POINT LABORATORIES LTD. stock is trading at a EV to sales ratio of 3.5565 and a EV to EBITDA ratio of 10.5465. Its price to sales ratio in the trailing 12-months stood at 4.1348.

CAPLIN POINT LABORATORIES LTD. stock pays annual dividends of ₹2.5 per share, indicating a yield of 0.24% and a payout ratio of 10.45%.

Balance sheet and cash flow metrics

Total Assets

₹21.91 billion

Total Liabilities

₹2.68 billion

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

10.45%

CAPLIN POINT LABORATORIES LTD. ended 2024 with ₹21.91 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹21.91 billion while shareholder equity stood at ₹18.80 billion.

CAPLIN POINT LABORATORIES LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹2.68 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹1.78 billion and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

CAPLIN POINT LABORATORIES LTD.’s total current assets stands at ₹15.54 billion while long-term investments were ₹0 and short-term investments were ₹5.47 billion. Its net receivables were ₹3.94 billion compared to accounts payable of ₹1.64 billion and inventory worth ₹2.88 billion.

In 2024, CAPLIN POINT LABORATORIES LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, CAPLIN POINT LABORATORIES LTD. paid ₹0.10 in dividends in 2024.

Other key metrics

Current Trading Price

₹972.85

52-Week High

₹1076.4

52-Week Low

₹573.5782

Analyst Target Price

₹

CAPLIN POINT LABORATORIES LTD. stock is currently trading at ₹972.85 per share. It touched a 52-week high of ₹1076.4 and a 52-week low of ₹1076.4. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹950.4 and 200-day moving average was ₹765.27 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.